Volume 374, Issue 9707, Pages 2080-2089 (December 2009) Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial Dr Shabbar Jaffar, PhD, Barbara Amuron, MSc, Prof Susan Foster, PhD, Josephine Birungi, MBChB, Jonathan Levin, PhD, Geoffrey Namara, BSc, Christine Nabiryo, MSc, Nicaise Ndembi, PhD, Rosette Kyomuhangi, MPH, Alex Opio, PhD, Rebecca Bunnell, PhD, Jordan W Tappero, MD, Jonathan Mermin, MD, Alex Coutinho, MD, Prof Heiner Grosskurth, PhD The Lancet Volume 374, Issue 9707, Pages 2080-2089 (December 2009) DOI: 10.1016/S0140-6736(09)61674-3 Copyright © 2009 Elsevier Ltd Terms and Conditions
Figure 1 Trial profile TASO=The AIDS Support Organisation. The Lancet 2009 374, 2080-2089DOI: (10.1016/S0140-6736(09)61674-3) Copyright © 2009 Elsevier Ltd Terms and Conditions
Figure 2 Kaplan-Meier curve of HIV-RNA virological suppression (A) and survival (B) The Lancet 2009 374, 2080-2089DOI: (10.1016/S0140-6736(09)61674-3) Copyright © 2009 Elsevier Ltd Terms and Conditions
Figure 3 Median (IQR) CD4-cell counts The Lancet 2009 374, 2080-2089DOI: (10.1016/S0140-6736(09)61674-3) Copyright © 2009 Elsevier Ltd Terms and Conditions
Figure 4 Proportion (95% CI) of patients reporting complete adherence in the past 28 days The Lancet 2009 374, 2080-2089DOI: (10.1016/S0140-6736(09)61674-3) Copyright © 2009 Elsevier Ltd Terms and Conditions